Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 75 /hr

★★★★★

☆☆☆☆☆

Hire Dr. James W.

United Kingdom

USD 75 /hr

PI moving into scientific and grant writing, backed by 25+ years of funding and publication success

Profile Summary

I am an experienced biomedical researcher and research leader with a strong track record in scientific writing, grant development, and research communication. Over a 25-year academic career, I have secured over £2 million in competitive funding as Principal Investigator, authored 52 peer-reviewed publications, and contributed to several patents and translational research programmes. My expertise lies in turning complex scientific concepts into clear, compelling narratives,from grants and manuscripts to impact cases, ethics submissions, strategic reports and student theses. I have successfully led major funding bids across the MRC, BHF, Fight for Sight, Dunhill Medical Trust, Macular Society and institutional proof-of-concept schemes, and have extensive experience mentoring researchers in proposal writing, project design and research storytelling. As Director of Graduate Studies at the William Harvey Research Institute, I supported a community of 120+ PhD researchers, strengthening their written communication, research progression and academic outputs. I have also served as Guest Editor across Cell Reports Medicine, Cell Reports and iScience, further deepening my experience in high-quality scientific editorial work. I’m now seeking opportunities in scientific writing, grant-writing consultancy, and research-development support, where I can apply my writing expertise, funding insights, and scientific judgement to help individuals, teams and organisations secure funding and communicate their science with impact.

Subject Matter Expertise

• ★ Biochemistry
• ★ Cell-Based Assays
• ★ Cell Surface Receptors
• ☆ Immunoassay
• ☆ Biochemical Assays
• ☆ Enzyme Activity Assays
• ☆ Binding Assays
• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ Microarrays
• ☆ PCR
• ☆ Molecular Cloning
• ☆ DNA Sequencing
• ☆ Gene Expression Analysis
• ☆ Recombinant DNA
• ☆ Plasmid DNA
• ☆ Cell Biology
• ☆ Cell Signaling Pathways
• ☆ Membrane Biology
• ☆ Gene Regulation
• ☆ Mycology
• ☆ Biomarker Discovery
• ☆ Cell Culture
• ☆ Primary Cells
• ☆ Cell Banking
• ☆ Cell Line Engineering
• ☆ 3D Cell Culture
• ☆ Blotting
• ☆ Immunohistochemistry
• ☆ Grant Writing

Services

• Research
• Consulting
• Data & AI
• Product Development

Research Scientific and Technical Research

Consulting Scientific and Technical Consulting

Data & AI Image Processing

Product Development Formulation, Stability/Shelf Life Testing, Product Evaluation

Work Experience

Reader

Queen Mary, University of London

August 2021 - August 2025

Senior Lecturer

Queen Mary, University of London

July 2016 - June 2021

Lecturer

Queen Mary, University of London

September 2014 - August 2016

Verses Arthritis Research Fellow

Queen Mary, University of London

March 2009 - August 2014

Post Doctoral Research Associate

University of Copenhagen

August 2007 - March 2009

Education

Postgraduate Certificate Academic Practice (PGCAP)

Queen Mary, University of London

2014 - 2016

PhD in Molecular Microbiology

King's College London

1994 - 1998

BSc Hons Applied Biology

King's College London

1991 - 1994

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Arokiasamy S, Balderstone MJM, Shaik F, Cristante E, Moseley TC, Madoo A, Rizzi M, Bainbridge JW, Tsoyi K, Rosas IO, et al. (2024). QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration . British journal of pharmacology.

Deshan Weeraman, Daniel A. Jones, Mohsin Hussain, Anne-Marie Beirne, Steven Hadyanto, Krishnaraj S. Rathod, James R. Whiteford, Alice E. Reid, Christos V. Bourantas, Seppo Ylä-Herttuala, et al. (2023). Proangiogenic Growth Factor Therapy for the Treatment of Refractory Angina: A Meta-analysis . Journal of the Society for Cardiovascular Angiography & Interventions.

Neutrophil breaching of the blood vessel pericyte layer during diapedesis requires mast cell-derived IL-17A <head> <META HTTP-EQUIV="Refresh" CONTENT="0;URL=/servlet/useragent"> </head> . Nature Communications.

James Whiteford (2022). Roles of Syndecan-4 in cardiac injury and repair . The international journal of biochemistry & cell biology.

James Whiteford (2021). CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis . American journal of respiratory and critical care medicine.

James Whiteford (2021). Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro . The FEBS journal.

James Whiteford (2021). Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization . Arteriosclerosis, thrombosis, and vascular biology.

James Whiteford (2021). Syndecan receptors: pericellular regulators in development and inflammatory disease . Open biology.

James Whiteford (2020). Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2 . Journal of cellular physiology.

Anne-Sophie Thorup, Danielle Strachan, Sara Caxaria, Blandine Poulet, Bethan L. Thomas, Suzanne E. Eldridge, Giovanna Nalesso, James R. Whiteford, Costantino Pitzalis, Thomas Aigner, et al.(2020). ROR2 blockade as a therapy for osteoarthritis . Science Translational Medicine. 12. (561). American Association for the Advancement of Science ({AAAS})

James Whiteford (2020). ROR2 blockade as a therapy for osteoarthritis . Science translational medicine.

James Whiteford (2020). Agrin induces long-term osteochondral regeneration by supporting repair morphogenesis . Science translational medicine.

James Whiteford (2020). Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling . Annals of the rheumatic diseases.

James Whiteford (2020). Syndecan-3 in Inflammation and Angiogenesis . Frontiers in immunology.

James Whiteford (2019). Translating the matrix . British journal of pharmacology.

James Whiteford (2016). Underlying chronic inflammation alters the profile and mechanisms of acute neutrophil recruitment . The Journal of pathology.

James Whiteford (2016). Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1 . FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

James Whiteford (2016). Mutually Supportive Mechanisms of Inflammation and Vascular Remodeling . International review of cell and molecular biology.

James Whiteford (2016). NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming . Cell reports.

James Whiteford (2015). ICAM-1-expressing neutrophils exhibit enhanced effector functions in murine models of endotoxemia . Blood.

James Whiteford (2015). Sex-specific regulation of chemokine Cxcl5/6 controls neutrophil recruitment and tissue injury in acute inflammatory states . Biology of sex differences.

James Whiteford (2015). Sexual dimorphisms in leukocyte trafficking in a mouse peritonitis model . Journal of leukocyte biology.

James Whiteford (2015). Interleukin-6 Stimulates Defective Angiogenesis . Cancer research.

James Whiteford (2014). Syndecans in angiogenesis and endothelial cell biology . Biochemical Society transactions.

James Whiteford (2014). Shed syndecan-2 inhibits angiogenesis . Journal of cell science.

James Whiteford (2013). Toll-like receptors: Role in inflammation and therapeutic potential . BioFactors (Oxford, England).

James Whiteford (2013). A novel role for syndecan-3 in angiogenesis . F1000Research.

James Whiteford (2013). ICAM-2 facilitates luminal interactions between neutrophils and endothelial cells in vivo . Journal of cell science.

James Whiteford (2013). Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer . FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

James Whiteford (2013). Critical Factors in Measuring Angiogenesis Using the Aortic Ring Model . Journal of genetic syndromes & gene therapy.

James Whiteford (2013). Novel insight into the biological functions of syndecan ectodomain core proteins . BioFactors (Oxford, England).

James Whiteford (2012). Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo . The Journal of experimental medicine.

James Whiteford (2011). Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148 . Molecular biology of the cell.

James Whiteford (2010). Heparan sulfate chain valency controls syndecan-4 function in cell adhesion . The Journal of biological chemistry.

James Whiteford (2009). Syndecan signaling: when, where and why?. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

James Whiteford (2009). Syndecan proteoglycan contributions to cytoskeletal organization and contractility . Scandinavian journal of medicine & science in sports.

James Whiteford (2008). Localization of Cladosporium fulvum hydrophobins reveals a role for HCf-6 in adhesion . FEMS microbiology letters.

James Whiteford (2008). Structural and cell adhesion properties of zebrafish syndecan-4 are shared with higher vertebrates . The Journal of biological chemistry.

James Whiteford (2008). The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors . BMC cell biology.

James Whiteford (2007). Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways . Experimental cell research.

James Whiteford (2006). A conserved NXIP motif is required for cell adhesion properties of the syndecan-4 ectodomain . The Journal of biological chemistry.

James Whiteford (2005). Structural basis of syndecan-4 phosphorylation as a molecular switch to regulate signaling . Journal of molecular biology.

James Whiteford (2004). Stage-specific cellular localisation of two hydrophobins during plant infection by the pathogenic fungus Cladosporium fulvum . Fungal genetics and biology : FG & B.

James Whiteford (2003). Production and secretion of Aspergillus nidulans catalase B in filamentous fungi driven by the promoter and signal peptide of the Cladosporium fulvum hydrophobin gene hcf-1 . Current genetics.

James Whiteford (2002). Hydrophobins and the interactions between fungi and plants . Molecular plant pathology.

James Whiteford (2001). The hydrophobin HCf-1 of Cladosporium fulvum is required for efficient water-mediated dispersal of conidia . Fungal genetics and biology : FG & B.

James Whiteford (2000). Genetic diversity in Proteus mirabilis isolates found in the urinary tract of rheumatoid arthritis patients . The Journal of infection.

James Whiteford(2000). Characterisation of xylanases produced in liquid and compost cultures of the cultivated mushroom Agaricus bisporus . Mycological Research. 104. (7). p. 810--819. Elsevier {BV}

James Whiteford (2000). The molecular genetics of cultivated mushrooms . Advances in microbial physiology.